AstraZeneca plc Stock
Price
Target price
€121.10
€121.10
-0.330%
-0.4
-0.330%
€135.00
27.01.23 / Tradegate
WKN: 886455 / Symbol: AZNCF / Name: AstraZeneca / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
AstraZeneca plc Stock
The price for the AstraZeneca plc stock decreased slightly today. Compared to yesterday there is a change of -€0.400 (-0.330%).
Currently there is a rather positive sentiment for AstraZeneca plc with 3 Buy predictions and 0 Sell predictions.
As a result the target price of €135.00 shows a slightly positive potential of 11.478% compared to the current price of €121.10 for AstraZeneca plc.
For the coming years our community has positive and negative things to say abot the AstraZeneca plc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of AstraZeneca plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AstraZeneca plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
AstraZeneca plc | -0.330% | -5.391% | -5.280% | 13.283% | -4.533% | 35.504% | 105.359% |
GSK plc | -0.250% | -0.858% | -2.764% | -19.901% | -1.341% | -24.322% | 2.172% |
Eli Lilly Corp. | -1.470% | -1.255% | -8.780% | 48.211% | -8.020% | 150.837% | 359.562% |
Merck KGaA | -1.710% | 1.413% | 6.255% | 0.848% | 4.763% | 62.329% | 110.035% |
Comments
Considering AZN's strong performance and the estimated growth of the sector due to COVID-19, we issue a buy recommendation.